Symptom Variability in Medication-Naïve Patients with Major Depressive Disorder as a Proxy to Predict Response to Treatment

Simple item page
dc.contributor.authorRosaline Abu Sabbah
dc.contributor.authorAbdul-Rahman S. Sawalma
dc.contributor.authorMohmmad M. Herzallah
dc.date.accessioned2022-06-22T11:54:54Z
dc.date.available2022-06-22T11:54:54Z
dc.date.issued2022-05-11
dc.description.abstractBackground: Major Depressive Disorder (MDD) is characterized by episodes of low mood and loss of interest for two or more consecutive weeks. It is considered to be the leading cause of morbidity and mortality worldwide. Only 30% of patients with MDD achieve full remission after treatment with antidepressants, psychotherapy or neuromodulation. It is unknown whether response to treatment depends on the baseline expression of MDD symptoms among patients.
dc.identifier.urihttps://hdl.handle.net/20.500.12213/6594
dc.language.isoen
dc.publisherAl-Quds University, Deanship of Scientific Research
dc.titleSymptom Variability in Medication-Naïve Patients with Major Depressive Disorder as a Proxy to Predict Response to Treatment
dc.typeArticle
dspace.entity.type
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Symptom Variability in Medication-Naïve Patients with Major Depressive Disorder as a Proxy to Predict Response to Treatment.pdf
Size:
324.8 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Neuroscience